Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 4 Brain Neoplasms 4 Neoplasms 3 Neoplasm Metastasis 3 Sarcoma 2 Multiple Myeloma 2 Lung Neoplasms 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Fatigue 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Thrombocytopenia 1 Symptom Management 1 Stomach Neoplasms 1 Splenomegaly 1 Sexual Dysfunction, Physiological 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Synovial 1 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroendocrine Tumors 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

Fluorouracil 267 Oxaliplatin 266 Capecitabine 224 Leucovorin 209 Irinotecan 151 Radiotherapy 131 Bevacizumab 112 Cetuximab 81 Folfox protocol 48 Surgical Procedures, Operative 44 Radiation 41 Drug Therapy 41 Neoadjuvant Therapy 40 Chemoradiotherapy 33 Chemotherapy, Adjuvant 32 Panitumumab 27 XELOX 25 Magnetic Resonance Spectroscopy 22 Radiotherapy, Intensity-Modulated 21 Floxuridine 17 Biopsy 16 Nivolumab 15 Gemcitabine 15 Early Intervention, Educational 15 pembrolizumab 14 Laparoscopy 14 IFL protocol 14 Celecoxib 14 trifluridine tipiracil drug combination 13 Gene Expression Profiling 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Rectal Neoplasms × Quality of Life × Clear all

NCT03459235 2018-05-18

Rectqol

University Hospital, Caen

Phase NA Unknown

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡